Efficacy and safety of remimazolam tosylate for sedation in ICU patients: A multicenter, randomized, phase 2 study
Journal of Intensive Medicine · 2026-06 · 6 (3) · 247-254
DOI: 10.1016/j.jointm.2026.01.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Intensive Medicine, 2026-06. Verfasst von Ning Liu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Hengrui Pharmaceuticals Co Ltd.
Themen: Intensivpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Intensive Care Unit, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China.
- Department of Intensive Care Unit, The First People's Hospital of Zunyi City, Zunyi, Guizhou, China.
- Department of Critical Care Medicine, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
- Department of Intensive Care Unit, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Intensive Care Unit, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Förderung
- Jiangsu Hengrui Pharmaceuticals Co Ltd
Zitieren
APA
Liu, N., Lin, F., Wen, J., Yu, X., Zhou, F., Yu, Z., Yang, M., Yu, L., Lv, A., Sun, Y., Shen, F., He, B., Hu, Z., Yin, T., Li, X., Zhao, H., Wu, J., Chen, C., Nie, Y., …, & Chen, M. (2026). Efficacy and safety of remimazolam tosylate for sedation in ICU patients: A multicenter, randomized, phase 2 study. Journal of Intensive Medicine, 6(3), 247-254. https://doi.org/10.1016/j.jointm.2026.01.009
Vancouver
Liu N, Lin F, Wen J, Yu X, Zhou F, Yu Z, et al. Efficacy and safety of remimazolam tosylate for sedation in ICU patients: A multicenter, randomized, phase 2 study. Journal of Intensive Medicine. 2026;6(3):247-254. doi:10.1016/j.jointm.2026.01.009
BibTeX
@article{Liu2026,
author = {Liu, Ning and Lin, Fenghui and Wen, Jianli and Yu, Xiangyou and Zhou, Fachun and Yu, Zhanbiao and Yang, Mei and Yu, Li and Lv, Ailian and Sun, Yun and Shen, Feng and He, Bin and Hu, Zhenjie and Yin, Tengrui and Li, Xi and Zhao, Huixin and Wu, Jianfeng and Chen, Chuanxi and Nie, Yao and Zuo, Lingyun and Guan, Xiangdong and Chen, Minying},
title = {Efficacy and safety of remimazolam tosylate for sedation in ICU patients: A multicenter, randomized, phase 2 study},
journal = {Journal of Intensive Medicine},
year = {2026},
volume = {6},
number = {3},
pages = {247--254},
doi = {10.1016/j.jointm.2026.01.009}
}
EUVIMED